Home > Boards > US Listed > Medical - Drugs > Catabasis Pharmaceuticals (CATB)

Vol increase, time to get this thing in gear.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
rivervalley Member Profile
 
Followed By 53
Posts 5,257
Boards Moderated 0
Alias Born 05/24/11
160x600 placeholder
Catabasis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides a Corporate Update Business Wire - 11/12/2020 4:10:00 PM
Catabasis Pharmaceuticals Announces Top-Line Results for the Phase 3 PolarisDMD Trial of Edasalonexent in Duchenne Muscular D... Business Wire - 10/26/2020 5:00:00 PM
Catabasis Pharmaceuticals Presents Information on Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystr... Business Wire - 9/28/2020 8:00:00 AM
Catabasis Pharmaceuticals to Present During the Virtual 25th International Congress of the World Muscle Society Business Wire - 9/23/2020 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/21/2020 8:11:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2020 8:09:13 AM
Catabasis Pharmaceuticals Names Noah Clauser Chief Financial Officer Business Wire - 9/21/2020 8:00:00 AM
Catabasis Pharmaceuticals to Present at Upcoming Virtual Investor Conferences Business Wire - 9/8/2020 8:00:00 AM
Catabasis Pharmaceuticals to Host Virtual KOL Event on Edasalonexent and Duchenne Muscular Dystrophy Business Wire - 9/2/2020 8:00:00 AM
Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress Business Wire - 8/10/2020 4:10:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:01:26 PM
Catabasis Pharmaceuticals to Present at Virtual 2020 Wedbush PacGrow Healthcare Conference Business Wire - 8/5/2020 8:00:00 AM
Catabasis Pharmaceuticals & Bill & Melinda Gates Medical Research Institute to Study CAT-5571 in Drug-Sensitive & Drug-Resist... Business Wire - 8/4/2020 8:00:00 AM
Catabasis Pharmaceuticals to Report Second Quarter 2020 Financial Results on Monday, August 10th Business Wire - 7/27/2020 8:00:00 AM
Catabasis Pharmaceuticals to Present at Parent Project Muscular Dystrophy Virtual Annual Conference Business Wire - 7/15/2020 8:00:00 AM
 Catabasis Joins Russell 3000® Index Business Wire - 6/29/2020 4:10:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:57:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:46:47 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:45:58 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:45:24 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:34:43 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/12/2020 8:12:53 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2020 8:10:59 AM
Catabasis Pharmaceuticals Names Ben Harshbarger Senior Vice President, General Counsel Business Wire - 6/12/2020 8:00:00 AM
Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress Business Wire - 5/12/2020 4:10:00 PM
rivervalley   Thursday, 06/08/17 11:03:46 AM
Re: None
Post # of 233 
Vol increase, time to get this thing in gear.

Posts are my opinion only and not to be considered as investment advice to others.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences